5XST
novel orally efficacious inhibitors complexed with PARP1
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRF BEAMLINE BL17U1 |
Synchrotron site | SSRF |
Beamline | BL17U1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2012-03-22 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.9793 |
Spacegroup name | P 65 2 2 |
Unit cell lengths | 93.980, 93.980, 222.800 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 39.709 - 2.300 |
R-factor | 0.203 |
Rwork | 0.202 |
R-free | 0.23560 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4hhy |
RMSD bond length | 0.008 |
RMSD bond angle | 0.960 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | PHENIX (1.11.1_2575: ???) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 39.709 | 39.709 | 2.360 |
High resolution limit [Å] | 2.300 | 10.290 | 2.300 |
Rmerge | 0.060 | 0.024 | 0.802 |
Rmeas | 0.065 | 0.026 | 0.876 |
Number of reflections | 48849 | 522 | 3609 |
<I/σ(I)> | 17.95 | 43.51 | 2.26 |
Completeness [%] | 99.9 | 94.6 | 99.9 |
Redundancy | 6.32 | 5.724 | 6.36 |
CC(1/2) | 0.999 | 0.999 | 0.759 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 283 | 80mM NaCl, 1.9M (NH4)2SO4 |